That’s pretty much how I feel about it; they’re clearly not driving up the price like they could, and seem to be keeping it relatively moderate. Who cares if they make a point or two more on this percentage-wise than other drugs, if it’s still not expensive? If they were sticking it to the government for $300 per dose or something, then yeah I’d be outraged. But at roughly $20 a shot? Let them have it and be glad that they can provide it for us.
The shareholders in these companies will appreciate any small dividends.
My mom bought J&J over 25 years ago. She may have some Pfizer. I need to check with her investment broker. All her stock was bought years ago for a retirement fund.